New bio-incubator is founded in Babraham Research Campus

| By | Bio-incubator, Drug Development, R&D
News

A new bio-incubator and life science accelerator capability has been launched at the Babraham Research Campus, Cambridge, UK.

Accelerate@Babraham is designed to support the earliest stages of new life-science ventures, by providing easy-access laboratory and office space, together with supporting programmes of business, science, finance and entrepreneurial mentoring provided by strategic partners. Accelerate@Babraham is supported by a number of strategic partners.  Current partners are AstraZeneca, MedImmune, One Nucleus and RxCelerate. Additional supporters will join the programme as it develops.

The aim of Accelerate@Babraham is to support the development of science concepts and the creation of new companies by providing access to equipped communal laboratories on short-term agreements, as well as guidance from mentors and introductions to investors.  The concept complements the Babraham Research Campus’ ongoing support of the Cambridge life science cluster through the provision of access to the campus community and infrastructure without the need to be an established occupier on site.

Companies will be able to access the fully equipped communal bio-incubator laboratory and offices on short-term licence agreements rather than lengthy leases.   In addition, they will also have access to practical advice from Accelerate@Babraham’s strategic partners and the wider Babraham Research Campus community, to help them develop their businesses and science into investable propositions.